首页> Journal of molecular medicine (Berlin, Germany)> Regimen-dependent synergism and antagonism of treprostinil and vildagliptin in hematopoietic cell transplantation.

Regimen-dependent synergism and antagonism of treprostinil and vildagliptin in hematopoietic cell transplantation.

导出 OA

翻译打印收藏纠错

第一作者： Eva,Zebedin-Brandl

第一单位： Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Medical University of Vienna, 1090, Vienna, Austria.

作者： Eva,Zebedin-Brandl ^[1] ; Madeleine,Themanns ^[1] ; Zahra,Kazemi ^[1] ; Shahrooz,Nasrollahi-Shirazi ^[1] ; Marion,Mussbacher ^[2] ; Elizabeth,Heyes ^[3] ; Katrin,Meissl ^[4] ; Michaela,Prchal-Murphy ^[5] ; Wolfgang,Strohmaier ^[6] ; Guenther,Krumpl ^[7] ; Michael,Freissmuth ^[8]

作者单位： Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Medical University of Vienna, 1090, Vienna, Austria. ^[1] Institute of Vascular Biology, Centre of Physiology and Pharmacology, Medical University of Vienna, 1090, Vienna, Austria. ^[2] Institute for Medical Biochemistry, University of Veterinary Medicine, 1210, Vienna, Austria. ^[3] Institute of Animal Breeding and Genetics, University of Veterinary Medicine, 1210, Vienna, Austria. ^[4] Institute of Pharmacology and Toxicology, Department of Biomedical Sciences, University of Veterinary Medicine, 1210, Vienna, Austria. ^[5] SciPharm SàRL, L-6689, Mertert, Luxembourg. ^[6] MRN Medical Research GmbH, Postgasse 11, 1010, Vienna, Austria. ^[7] Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Medical University of Vienna, 1090, Vienna, Austria. michael.freissmuth@meduniwien.ac.at. ^[8]

关键词 DPP4/CD26-inhibitor Drug combination therapy Engraftment Hematopoietic cell transplantation/HCT Homing Migration Prostanoid receptor agonist